Motley Fool analysts discuss the challenges biotech companies face when they walk the fine line between patient centered medicine and profit.

Motley Fool analysts discuss the challenges biotech companies face when they walk the fine line between patient centered medicine and profit.

Motley Fool analysts discuss the challenges&nbsp;biotech companies face when they&nbsp;walk&nbsp;the fine line&nbsp;between patient&nbsp;centered medicine and profit.

Heathcare: Have Ethics Become Passe in Biotech?

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.

Share Heathcare: Have Ethics Become Passe in Biotech?

Sign up to save your podcasts

Heathcare: Have Ethics Become Passe in Biotech?

Heathcare: Have Ethics Become Passe in Biotech?

More shows like Industry Focus

Motley Fool Hidden Gems Investing

Motley Fool Answers

Rule Breaker Investing

MarketFoolery